Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients.
about
Influence of pharmacogenetics on indinavir disposition and short-term response in HIV patients initiating HAARTCYP2C19 genetic variants affect nelfinavir pharmacokinetics and virologic response in HIV-1-infected children receiving highly active antiretroviral therapy.Joint population pharmacokinetic analysis of zidovudine, lamivudine, and their active intracellular metabolites in HIV patientsMinimising harm: human variation and adverse drug reactions (ADRs)Functional genetic polymorphisms in CYP2C19 gene in relation to cardiac side effects and treatment dose in a methadone maintenance cohort.Influence of CYP2C19 polymorphism on the pharmacokinetics of nelfinavir and its active metabolite.Pharmacogenetics and population pharmacokinetics: impact of the design on three tests using the SAEM algorithm.
P2860
Q34012749-43E926CD-E521-4FF5-B399-3FBDFC96A49BQ35057831-9076701D-C564-4AAA-8D5F-60147723AB55Q35065817-F9C2E5F2-D219-4C57-8017-875A7B950E7BQ36536395-9F1850FD-1B45-4B69-902A-3B5AEEDEA93CQ37199426-37E36C8F-F985-4277-9856-628518445111Q37471054-6477343A-5F4C-4289-BA17-E0C7F0856AD5Q38691481-78399C0F-4502-47C9-92E6-1C0C5538B206
P2860
Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients.
@ast
Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients.
@en
type
label
Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients.
@ast
Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients.
@en
prefLabel
Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients.
@ast
Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients.
@en
P2093
P2860
P1476
Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients.
@en
P2093
Agnès Tran
COPHAR2- ANRS Study Group
Dominique Salmon
Déborah Hirt
Elisabeth Rey
France Mentré
Jean-Marc Tréluyer
Solange Auleley
Xavier Duval
P2860
P304
P356
10.1111/J.1365-2125.2007.03039.X
P407
P577
2007-10-08T00:00:00Z